Tel Aviv Sourasky Medical Center (TASMC)
Tel Aviv, Israel
NCT Number: NCT04179279
This is a prospective pivotal study in patients admitted/visiting the cardiology ward and/or outpatient clinics for various indications.
The study will be conducted in two stages. The first stage will comprise a pilot study with 10 subjects, which will be completed and analyzed prior to initiation of the second stage. The two studies are independent and are included in the same protocol for logistical reasons. The second stage of the study, which will include 120 subjects, is pivotal and intended to validate the Gili BioSensor System.
Testing procedure will include seating the subject in either a steady chair in front of a table, or in bed with the bedrest raised in front of a cardiac table (or similar). The subject will be seated for 5 minutes to reach a physiological steady state. During this time, the subject will be connected to the reference device according to the manufacturer's guidelines. The investigational device will be placed on a stable surface in front of the subject (table / cardiac table or similar) and will point to the left side of the subject's chest. Both the investigational and reference devices will be temporally synchronized to maintain coordinated recording. Following the 5-minute resting period, both investigational and reference devices will be activated for a comparative recording session to acquire at least 180 seconds (3 minutes) of evaluable data. Each 60-sec interval will be used separately for comparative analyses.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Tel Aviv, Israel
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Non-contact monitoring of heart and respiratory rates using an optical device
Time frame: During the procedure
Heart rate will be compared to a reference:
Time frame: During the procedure
Respiratory rate will be compared to a reference:
Time frame: During the procedure
The Gili BioSensor System functions without physical contact with the inspected subject, and is compared in this study to a reference device routinely used as standard of care (SOC). Consequently, we do not expect any safety issues. At the same time, any adverse events (AE) observed during the procedure and/or during the study and/or follow-up period will be recorded in the CRF.
ContinUse Biometrics Ltd.
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07477834
Air Pollution Exposure, HRV
Abu Dhabi, United Arab Emirates
View Trial DetailsNCT05889832
Heart Rate, Heart Rate Variability
Wroclaw, Lower Silesian Voivodeship, Poland
View Trial DetailsNCT05366049
Body Temperature Changes, Fever
Istanbul, Fatih, Turkey (Türkiye)
View Trial DetailsNCT03754231
Heart Rate, Respiratory Rate
Singapore
View Trial Details